Free tool

Oncology stocks

We cover 14 companies grouped under the Oncology theme. The median market value in the group is $598.76M. Across the group, the median move over the past trading day is +0.63%. Price change over the past year runs from −21.8% to +306.7% across the middle 80 percent of the group, with a median of +46.5%. Across the group, 1 company currently carries a tier A volume signal.

Other lists in this group

Table

14 of 319 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y returnNext report
0J9P.LIncyte Corporation$21.10BLarge cap+53.49%Oct 27, 2026
GE9.DEGenmab A/S$20.65BLarge cap−11.12%Nov 5, 2026
VIRVir Biotechnology, Inc.$1.87BSmall cap+111.85%Nov 4, 2026
INBXInhibrx Biosciences, Inc.$1.81BSmall cap+357.45%Nov 13, 2026
CGEMCullinan Therapeutics, Inc.$1.48BSmall cap+188.15%Nov 5, 2026
JANXJanux Therapeutics, Inc.$1.15BSmall cap−19.10%Nov 5, 2026
SGMTSagimet Biosciences Inc.$675.04MSmall cap+39.59%Nov 12, 2026
PRLDPrelude Therapeutics Incorporated$522.47MSmall cap+412.50%Nov 11, 2026
0LOV.LVerastem, Inc.$470.33MSmall cap−19.93%Nov 3, 2026
0XOD.LUroGen Pharma Ltd.$347.24MSmall cap+136.88%Nov 5, 2026
CRBPCorbus Pharmaceuticals Holdings, Inc.$218.56MSmall cap+7.93%Nov 16, 2026
HOWLWerewolf Therapeutics, Inc.$48.05MMicro cap−25.65%Oct 30, 2026
KYNBKyntra Bio, Inc.$32.82MMicro cap−22.66%Nov 9, 2026
BFRIBiofrontera Inc.$22.72MMicro cap+77.91%Nov 11, 2026

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse